TMO

Thermo Fisher Scientific Inc.
$448.28
-1.09 (-0.24%)
Mkt Cap 166.59B
Volume 1,408,703
52W Range 385.46-643.99
Sector Healthcare
Beta 0.88
EPS (TTM) 18.22
P/E Ratio 24.60
Revenue (TTM) 45.20B
Rev Growth (5Y) +6.7%
EPS Growth (5Y) +2.0%
AlphaVal · Fair Value
$419.11
Overvalued · Mild
7.0% above fair value
AlphaQuality · Grade
C+
Stable Earnings Power
60.0 / 100 composite

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 44.56B 42.88B 42.86B 44.91B 39.21B 32.22B 25.54B 24.36B 20.92B 18.27B 16.97B 16.89B
Net Income 6.74B 6.33B 6.00B 6.95B 7.72B 6.38B 3.70B 2.94B 2.23B 2.02B 1.98B 1.89B
EPS 17.77 16.58 15.53 17.73 19.61 16.10 9.24 7.31 5.64 5.12 4.96 4.76
Free Cash Flow 6.29B 7.27B 6.93B 6.91B 7.02B 6.82B 4.05B 3.79B 3.50B 2.71B N/A N/A
FCF / Share 16.74 19.02 17.95 17.63 17.82 17.21 10.12 9.42 8.85 6.87 N/A N/A
Operating CF 7.82B 8.67B 8.41B 9.15B 9.54B 8.29B 4.97B 4.54B 4.00B 3.16B N/A N/A
Total Assets 110.34B 97.32B 98.73B 97.15B 95.12B 69.05B 58.38B 56.23B 56.67B 45.91B N/A N/A
Total Debt 40.85B 32.77B 36.42B 36.07B 36.34B 22.55B 18.49B 18.99B 21.01B 16.63B N/A N/A
Cash & Equiv 9.86B 4.02B 8.08B 8.52B 4.48B 10.32B 2.40B 2.10B 1.33B 786.00M N/A N/A
Book Value 53.41B 49.58B 46.73B 43.98B 40.79B 34.51B 29.68B 27.59B 25.41B 21.54B N/A N/A
Return on Equity 0.13 0.13 0.13 0.16 0.19 0.18 0.12 0.11 0.09 0.09 N/A N/A
TMO News
Thermo Fisher Scientific Inc. (TMO) Analyst/Investor Day Transcript
May 22, 2026 01:40 PM · seekingalpha.com
Thermo Fisher Scientific Announces Quarterly Dividend
May 20, 2026 01:00 PM · businesswire.com
Thermo Fisher Scientific Highlights Industry Leadership, Growth Outlook and Long-Term Value Creation at 2026 Investor Day
May 20, 2026 04:30 AM · businesswire.com
Amazon, McDonald Surge Into Jefferies Top Picks Broadcom as Gets Cut
May 19, 2026 05:47 AM · gurufocus.com
Jefferies updates its list of highest-conviction Buy-rated stocks
May 18, 2026 06:34 AM · finbold.com
Thermo Fisher Scientific's PPD Clinical Research Business Expands Bioanalytical Capabilities with New Laboratory in Gothenburg, Sweden
May 18, 2026 04:30 AM · businesswire.com
Nalgene Outdoor Introduces Fresh Flow™ Straw Bottle
May 11, 2026 04:30 AM · businesswire.com
TMO DCF Analysis: Intrinsic Value $478 vs Price $465
May 11, 2026 04:19 AM · gurufocus.com
Thermo Fisher Scientific's Clinical Research Business Named a Leader Among CROs in 2026 ISG Provider Lens™ Report for Use of AI in Clinical Trials
May 06, 2026 04:30 AM · businesswire.com
International Markets and Thermo Fisher (TMO): A Deep Dive for Investors
May 04, 2026 06:16 AM · zacks.com